Under construction – not a live service
Sign in
Not yet taking people in DenmarkNo phase

Same-Day Cochlear Implant Activation (SDA-CI)

Key facts

Where
Aarhus, DenmarkSee the site

Where in Denmark

  • Aarhus University HospitalAarhus, DenmarkContact: Louise Devantier, MD, PhDNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
University of Aarhus
Trial code
NCT07681830
Record updated
2 July 2026
Original description
This randomized controlled study investigates whether activating a cochlear implant on the day of surgery (same-day activation) leads to faster stabilization of cochlear implant programming compared with the current standard practice of activation approximately 14 days after surgery.Read full original descriptionShow less

Randomized Study of Same-Day Activation Versus Day-14 Activa- Tion in Adult Cochlear Implant Recipients

This randomized controlled study investigates whether activating a cochlear implant on the day of surgery (same-day activation) leads to faster stabilization of cochlear implant programming compared with the current standard practice of activation approximately 14 days after surgery.

Adult cochlear implant recipients at Aarhus University Hospital will be randomly assigned to either same-day activation or standard activation. The study will evaluate electrode impedance development, time to a stable cochlear implant map, changes in programming parameters, hearing outcomes, tinnitus, quality of life, rehabilitation progress, and safety.

The purpose of the study is to determine whether earlier activation can facilitate faster auditory rehabilitation and optimization of cochlear implant settings without increasing complications or patient discomfort.

Inclusion: Age 18 years or older; Indication for cochlear implantation according to national guidelines; Ability to provide written informed consent.

Exclusion: -.

ClinicalTrials.gov NCT07681830